Bernard–Soulier syndrome is a rare inherited bleeding disorder. In BSS, platelets are abnormally large and often fewer than normal. Doctors call this “macro-thrombocytopenia.” The main problem is that platelets cannot stick well to the injured blood vessel wall because a key surface receptor (the GPIb–IX–V complex) is missing or not working. This receptor normally grabs von Willebrand factor (vWF) to start the first step of clotting. Because that first step is weak, people with BSS bruise easily and bleed longer than usual from the nose, gums, or cuts, and women can have heavy periods. Standard clotting tests like PT and aPTT are usually normal, which can make BSS easy to miss without special platelet tests. BioMed Central+2PMC+2

Bernard–Soulier syndrome is a rare, lifelong bleeding disorder you are born with. In BSS, platelets (the tiny blood cells that help form clots) are fewer in number and much larger than normal. They also cannot stick well to damaged blood vessel walls because a surface “grip” called the GPIb–IX–V receptor does not work properly. As a result, people bruise easily, get nosebleeds and gum bleeds, bleed more with dental work or surgery, and some have heavy menstrual bleeding. BSS is usually inherited (often recessive) from both parents. Doctors diagnose it with blood counts, a smear (to see the big platelets), tests that show poor response to ristocetin, and flow cytometry to show lack or loss of the GPIb–IX–V complex. Management focuses on preventing bleeds and treating them promptly; platelet transfusion is the main rescue therapy for serious bleeding or procedures. Recombinant factor VIIa and antifibrinolytics can help in selected situations. Gene and stem-cell approaches remain experimental. Medscape+4NCBI+4National Organization for Rare Disorders+4

Other names

BSS is also known as “hemorrhagiparous thrombocytic dystrophy,” “giant platelet syndrome” (used broadly, not only for BSS), and “macro-thrombocytopenia due to GPIb–IX–V defect.” These names all point to the same core idea: big, low-number platelets that do not adhere well. PubMed+1

In classic BSS, mutations in the genes GP1BA, GP1BB, or GP9 prevent the normal build-up or function of the platelet surface receptor GPIb–IX–V. Without this receptor, platelets cannot bind vWF under blood flow, so they cannot start a stable plug at sites of injury. Most families show autosomal recessive inheritance (two non-working copies are needed). Rarely, a single harmful copy can cause a milder, “monoallelic” macro-thrombocytopenia with similar features. PubMed+2PMC+2

---

Types

1. Classic (biallelic) inherited BSS. Both copies of one of the genes (GP1BA, GP1BB, or GP9) are faulty. Platelet adhesion via vWF is strongly impaired, bleeding can be mild to severe, and platelets look very large on a blood smear. BioMed Central

2. Monoallelic (heterozygous) BSS / macro-thrombocytopenia variants. A single pathogenic variant, sometimes specific ones like GP1BA missense variants, can produce big platelets and mild bleeding. The receptor level or function is partly reduced rather than absent, so symptoms may be milder. PMC

3. Acquired (pseudo-) Bernard–Soulier syndrome. Not genetic. Autoantibodies, immune disorders, or certain hematologic conditions damage or block the GPIb–IX–V receptor, “mimicking” inherited BSS in tests (low/absent ristocetin response and large platelets). Management targets the trigger as well as bleeding. Haematologica+1

---

Causes

Note: For inherited BSS, “cause” means the specific genetic or biological reason platelets cannot adhere. For acquired BSS, “cause” means an outside process that blocks the receptor.

1. GP1BA missense variants (biallelic). A small change in the GPIbα protein changes its shape so vWF cannot bind well. PubMed

2. GP1BA nonsense or frameshift variants. These changes stop the protein early, so the receptor never forms. PubMed

3. GP1BA splice-site variants. The gene is cut and pasted wrongly, producing a faulty receptor. PubMed

4. Large deletions in GP1BA. Whole gene segments are missing, leaving no receptor part to build. PubMed

5. GP1BB missense variants (biallelic). The GPIbβ subunit misfolds, so the complex cannot assemble or reach the surface. PubMed

6. GP1BB truncating variants. The subunit is incomplete; surface expression fails. ASH Publications

7. GP9 missense variants (biallelic). Faulty GPIX prevents stable assembly of the complex. PubMed

8. GP9 truncating/splice variants. The GPIX piece is absent or malformed, again blocking assembly. PubMed

9. Compound heterozygosity across GP1BA/GP1BB/GP9. Two different damaging variants together disable the complex. Frontiers

10. Monoallelic GP1BA variants causing macro-thrombocytopenia. One altered copy can reduce receptor density and mildly impair function. PMC

11. Defects that disrupt trafficking of the complex. The receptor is built but cannot reach the platelet surface. PMC

12. Megakaryocyte maturation defects secondary to these variants. Platelet production becomes inefficient, adding to low counts. BioMed Central

13. Acquired autoantibodies to GPIb–IX–V. The immune system blocks or removes the receptor; tests look like BSS. ScienceDirect

14. Autoimmune diseases with anti-platelet antibodies. Conditions like immune dysregulation can cause BSS-like findings. Haematologica

15. Lymphoproliferative or myeloid disorders with receptor targeting. Some blood cancers or pre-cancers are linked to acquired BSS. Haematologica

16. GATA2 deficiency leading to pseudo-BSS. A genetic immune disorder that can unmask acquired BSS features. Haematologica+1

17. Alloimmune antibodies (post-transfusion/pregnancy). Rarely, antibodies from exposure to other platelets target GPIb–IX–V. ScienceDirect

18. Drug-related immune reactions (rare reports). Some medications can trigger anti-GPIb antibodies, producing a transient BSS pattern. ScienceDirect

19. Paraproteins in plasma cell disorders. Abnormal proteins can bind platelet receptors and block function. Semantic Scholar

20. Severe secondary platelet membrane injury. In rare settings, membrane damage can reduce effective receptor display and mimic BSS-like adhesion failure. PMC

---

Symptoms

1. Easy bruising. Dark skin marks happen after very small bumps because platelets cannot start clots well. BioMed Central

2. Frequent nosebleeds. The nose lining bleeds easily and takes longer to stop. PubMed

3. Bleeding gums. Brushing teeth or dental work can bleed more than normal. PubMed

4. Prolonged bleeding from small cuts. A small cut may ooze for a long time because first-step clotting is weak. BioMed Central

5. Heavy menstrual bleeding. Periods can be long or heavy, with clots, causing tiredness from iron loss. PubMed

6. Post-surgery or post-dental bleeding. After procedures, bleeding may restart or take longer to settle. BioMed Central

7. Petechiae or purpura. Tiny red dots or purple patches appear from bleeding under the skin. National Organization for Rare Disorders

8. Prolonged bleeding after childbirth. Women may need special planning with the care team. BioMed Central

9. Blood in urine (hematuria). Sometimes the urinary tract bleeds. National Organization for Rare Disorders

10. Blood in stool or black stools. Bleeding in the gut can show as red blood or tarry stool. PubMed

11. Prolonged oozing from injection sites. Needlesticks may bleed longer. BioMed Central

12. Anemia symptoms (from chronic blood loss). Tiredness, pale skin, and shortness of breath can result from iron loss. BioMed Central

13. Bleeding after sports injuries. Even minor injuries may bruise or swell more. BioMed Central

14. Rare severe internal bleeding. Serious bleeds (e.g., in the brain) are uncommon but possible in severe cases. BioMed Central

15. No symptoms at times. Some people have mild disease and notice problems only during surgeries or dental work. Medscape

---

Diagnostic tests

A) Physical examination

1. Skin and mucosa check. The clinician looks for petechiae, purpura, and gum bleeding. These signs suggest a platelet-type bleeding problem rather than a factor deficiency. BioMed Central

2. Nose, mouth, and dental exam. Frequent nose and gum bleeding support a primary platelet disorder like BSS. PubMed

3. Menstrual history and pelvic exam (when relevant). Heavy periods point toward platelet adhesion problems. PubMed

4. Family history and bleeding score. Autosomal recessive patterns or consanguinity raise suspicion for inherited BSS; a structured bleeding score helps quantify risk. BioMed Central

B) Manual / bedside platelet function screening

5. PFA-100 / PFA-200 closure time. This cartridge test measures how fast platelets form a plug under flow. In BSS, times are often prolonged because adhesion to vWF is poor. It is a screening tool, not a final diagnosis. BioMed Central

6. Historical bleeding time (rarely used now). An older, operator-dependent test; often prolonged in BSS but largely replaced by modern methods. BioMed Central

7. Tourniquet (capillary fragility) assessment. Not specific. Can show easy skin bleeding but cannot confirm BSS; it may help support the clinical picture. BioMed Central

C) Laboratory and pathological tests

8. Complete blood count (CBC). Platelet count is often low to low-normal, and automated counters may undercount because platelets are very large. Medscape

9. Peripheral blood smear. A human reviewer sees giant platelets, a hallmark of BSS, helping separate it from other causes of low platelets. Medscape

10. Mean platelet volume (MPV). MPV is high, reflecting unusually large platelets. This supports the diagnosis with the smear. BioMed Central

11. PT and aPTT. These clotting tests are usually normal because the problem is platelet adhesion, not clotting factors. Normal results steer testing toward platelet function. BioMed Central

12. von Willebrand factor panel (vWF:Ag, vWF activity, Factor VIII). In BSS, vWF levels are typically normal, which helps distinguish BSS from von Willebrand disease (vWD). BioMed Central

13. Light transmission aggregometry (LTA). Platelets respond normally to most agonists but fail to agglutinate with ristocetin in BSS. This is a key pattern. PMC+1

14. Ristocetin-induced platelet aggregation (RIPA) characterization. In BSS, the low ristocetin response is not corrected by adding normal plasma (because the platelet receptor—not plasma vWF—is the problem). This helps distinguish BSS from vWD. American Journal of Medicine

15. Flow cytometry for CD42 (GPIb/IX/V). Measures how much of the receptor is on platelet surfaces. In BSS, levels are reduced or absent. This is a strong confirmatory test. BioMed Central

16. Molecular genetic testing (GP1BA, GP1BB, GP9). Sequencing finds the exact variant(s) and confirms inherited BSS. It also helps with family counseling. PubMed+1

D) Electrodiagnostic / device-based platelet function tests

17. Impedance aggregometry (electrical signal). This machine reads changes in electrical resistance as platelets clump. In BSS, ristocetin-based signals are low because adhesion/agglutination is defective. Wikipedia

18. Lumi-aggregometry (ATP release plus aggregation). Adds a light signal from ATP release to gauge secretion and clumping. In BSS, the problem is primarily adhesion/agglutination to ristocetin; patterns help separate BSS from secretion defects. Wikipedia

E) Imaging and procedure-based tests

19. Targeted imaging to look for bleeding (site-specific). If symptoms suggest internal bleeding, doctors may order ultrasound or CT scans (e.g., abdomen for suspected organ bleeding) to find the source. Imaging does not diagnose BSS but finds complications. BioMed Central

20. Endoscopy for GI bleeding. If stools are black or bloody, endoscopy identifies and treats the bleeding site; the underlying platelet problem remains BSS. PubMed

21. Pelvic ultrasound for heavy periods. Helps rule out structural uterine problems when assessing menorrhagia in someone with BSS. PubMed

22. Brain CT/MRI (if neurological signs). Rare but important when severe headache, neurological deficits, or trauma raise concern for intracranial bleed. BioMed Central

23. Dental evaluation with local hemostasis planning. A focused oral exam helps plan preventive measures (e.g., tranexamic acid mouthwash, local pressure) before dental work. BioMed Central

Non-pharmacological treatments

1) Carry a bleeding-disorder plan + medical alert.
Keep a wallet card or phone note that says “Bernard–Soulier syndrome (inherited platelet disorder)” with your hematologist’s contact. Share it before dental work, surgery, or new medicines. Early disclosure prevents harmful drugs (e.g., aspirin/NSAIDs) and speeds the right care. haematologica.org

2) Avoid platelet-inhibiting medicines and risky supplements.
Aspirin, many NSAIDs, and several other drugs can worsen bleeding. Some herbal or dietary products (e.g., ginkgo, high-dose garlic, high-dose fish oil/omega-3) may also increase bleeding risk—especially around procedures—so discuss everything you take with your clinician. FDA Access Data+3haematologica.org+3PubMed+3

3) Everyday injury prevention.
Use soft toothbrushes, electric razors, seatbelts/helmets, and protective gear. For sports, prefer non-contact activities; avoid high-impact/contact sports if you’ve had bleeding with minor trauma or platelet counts are very low. haematologica.org

4) Menstrual management planning.
If periods are heavy, document flow (apps), check for anemia, and discuss medical options (e.g., antifibrinolytics or hormonal therapy) and surgical back-ups with gynecology in advance of life events. Adolescents with heavy bleeding should be evaluated for bleeding disorders and anemia. contemporaryobgyn.net

5) Dental hygiene, prevention, and planning.
Excellent brushing/flossing and routine cleanings reduce the need for invasive dental work. Before extractions or periodontal surgery, coordinate with hematology; local hemostatic tactics (pressure, sutures, collagen/oxidized cellulose, fibrin sealant, tranexamic mouthwash) are widely recommended. WFH+1

6) First-aid for cuts and scrapes.
Apply firm pressure with clean gauze for 10–15 minutes without peeking; add a pressure bandage if needed. For oozing wounds, local hemostatic dressings (e.g., fibrin/gelatin/oxidized cellulose) can help—ask your care team what’s appropriate to keep at home. WFH

7) Nosebleed self-care.
Lean forward, pinch the soft part of the nose continuously for 10–15 minutes. If persistent, add oxymetazoline or phenylephrine nasal spray and continue compression; seek care if bleeding won’t stop or recurs frequently. AAO-HNS+1

8) Procedure “game plan.”
For dental/surgical procedures, your team may pre-plan with antifibrinolytics, local measures, and—when necessary—platelet transfusions (preferably leukoreduced/ABO-identical; HLA-matched if prior alloimmunization). haematologica.org

9) Pregnancy and delivery planning.
Most pregnancies progress normally, but delivery bleeding risk is higher. Plan delivery at centers familiar with bleeding disorders, share BSS status early, and coordinate anesthesia and postpartum hemostasis plans. haematologica.org

10) Anemia prevention and treatment.
Heavy menstrual or recurrent mucosal bleeding can cause iron-deficiency anemia. Screening and iron repletion improve symptoms and may indirectly reduce bleeding risk by normalizing red cell mass. haematologica.org

11) Vaccination and infection prevention if splenectomy considered.
Splenectomy is rarely used in BSS; if ever planned, ensure appropriate vaccinations (pneumococcal, meningococcal, Hib) and infection-prevention counseling. Medscape

12) Gentle nasal/oral moisturization.
For frequent nosebleeds or gum bleeding, regular saline sprays/gel and humidification reduce mucosal dryness and cracking that can trigger bleeds. AAO-HNS

13) Travel prep kit.
Carry a small kit: gauze, medical tape/elastic bandage, written care plan, and phone numbers for local hematology centers at your destination when traveling. haematologica.org

14) Early dental/ENT referral for recurrent sites.
Persistent gum or nasal bleeding benefits from targeted local therapy (e.g., dental debridement with hemostatics, silver nitrate cautery for a visible anterior nasal source). PubMed

15) Period products that fit your flow.
High-absorbency pads or period underwear can reduce leakage anxiety. Discuss tampon/menstrual cup use with your clinician if you have frequent clots or ongoing bleeding. contemporaryobgyn.net

16) Avoid intramuscular injections when possible.
Use subcutaneous or oral routes to lower hematoma risk; if IM is unavoidable, apply prolonged pressure afterward. haematologica.org

17) Structured exercise.
Regular low-impact exercise supports cardiovascular health and fall prevention; tailor activities to your bleeding history and platelet levels. haematologica.org

18) Early treatment “windows.”
At the first sign of a bleed (nose, mouth, menses, wound), start pressure and call your plan (local measures ± antifibrinolytic). Early action reduces ER visits. WFH

19) Multidisciplinary care.
Hematology, dentistry, ENT, gynecology, anesthesia, and primary care should share a single plan for you; this coordination is central in rare inherited platelet disorders. haematologica.org

20) Education for family/school/work.
Share simple instructions for first aid, medicines to avoid, and when to seek urgent help. Empowered supporters reduce delays. haematologica.org

---

Drug treatments

There are no FDA-approved drugs specifically for BSS. Clinicians use medicines that help clotting in mucosal sites or around procedures. Below are commonly used options (with FDA label sources for the drug itself); use only under specialist guidance.

1) Tranexamic acid (oral tablets).
Used for heavy periods and mucosal bleeding; typical adult dosing for heavy menstrual bleeding is 1,300 mg orally three times daily for up to 5 days per cycle. It blocks plasminogen activation so clots are more stable; not a substitute for platelets but reduces mouth/nose/uterine bleeding. Possible side effects: nausea, cramps; avoid in active intravascular clotting. Label: Lysteda® (tranexamic acid). PubMed

2) Tranexamic acid (IV).
For peri-operative support or when oral dosing isn’t feasible. Mechanism identical; dosing individualized by procedure and renal function. Watch for hematuria-related obstruction if gross blood is in urine. Label: tranexamic acid injection. PMC

3) Epsilon-aminocaproic acid (EACA; oral/IV).
Another antifibrinolytic used for dental, ENT, or surgical bleeds; mechanism: lysine analogue that inhibits plasminogen activation. Side effects: GI upset; caution with hematuria. Label: Amicar®. Office of Dietary Supplements

4) Desmopressin (DDAVP; IV/SC/IN).
Sometimes used for mucosal bleeding; it releases vWF and FVIII. Benefit in BSS is variable (since the core problem is platelet adhesion), so it’s case-by-case and often adjunctive. Side effects: hyponatremia (fluid restriction often needed). Label: DDAVP. AAO-HNS Bulletin

5) Recombinant activated Factor VII (eptacog alfa; NovoSeven RT®).
A “bypassing” agent used off-label when platelet transfusion is ineffective or contraindicated (e.g., anti-GPIb antibodies), and around certain surgeries. It directly activates factor X to generate thrombin and stabilize clots. Thrombosis is the key risk; use only with hematology. Label: NovoSeven RT. ResearchGate

6) Recombinant activated Factor VII (eptacog beta; Sevenfact®).
Another rFVIIa product (approved for hemophilia with inhibitors) sometimes considered off-label in severe platelet function disorders when other measures fail. Strict thrombotic monitoring is required. Label: Sevenfact®. sevenfact.com

7) Topical fibrin sealant (e.g., Tisseel®).
Applied locally by surgeons/dentists to help stop bleeding by providing concentrated fibrinogen/thrombin where needed. Helpful adjunct in dental and surgical fields. Label: Tisseel. Office of Dietary Supplements

8) Topical thrombin (e.g., Recothrom®).
Directly converts fibrinogen to fibrin at the bleeding surface; used as an adjunct to surgical hemostasis. Label: Recothrom. Office of Dietary Supplements

9) Oxymetazoline/phenylephrine nasal sprays (local vasoconstrictors).
Over-the-counter decongestant sprays that constrict nasal vessels to control epistaxis; used with compression per ENT guidelines (off-label for BSS). Side effects: rebound congestion with overuse. Guideline evidence: AAO-HNS epistaxis CPG. PubMed

10) Combined oral contraceptives (estrogen-progestin).
For heavy menstrual bleeding control and cycle regulation; reduce endometrial bleeding. Risks include thromboembolism (patient-specific). Guideline evidence: ACOG adolescent HMB guidance. contemporaryobgyn.net

11) Levonorgestrel intrauterine system (LNG-IUS; Mirena®).
Markedly reduces menstrual blood loss; can be a strong option for people with bleeding disorders who desire contraception and HMB control. Label: Mirena® prescribing information. FDA Access Data+1

12) Progestin-only regimens (e.g., medroxyprogesterone).
An alternative when estrogen isn’t suitable; suppresses endometrium to decrease menstruation. Use per gynecology guidance; risks include irregular spotting. Guideline evidence: ACOG options for HMB. ACOG

13) Iron therapy (oral/IV) for iron-deficiency anemia.
Not a hemostatic drug, but often essential if chronic bleeding causes anemia; improves fatigue and quality of life and supports safer procedural care. Evidence overview: NIH ODS Iron Fact Sheet. U.S. Food and Drug Administration

14) Local dental hemostatics with antifibrinolytic mouthwash.
Dentists often combine suturing, collagen/oxidized cellulose, topical thrombin, and 5–10% tranexamic or EACA mouthwash after extractions to reduce oral bleeding (off-label). WFH+1

15) Platelet transfusion (leukoreduced; HLA-matched when possible).
Not a “drug,” but the mainstay for major bleeds/procedures in BSS. Use leukoreduced/ABO-identical products; in those with anti-GPIb/IX or anti-HLA antibodies, crossmatch or HLA-matched units are preferred; irradiate in at-risk groups to prevent TA-GVHD. haematologica.org

16) rFVIIa for transfusion-refractory cases (case reports in BSS).
Clinical reports document benefit of rFVIIa in BSS when platelet transfusions fail or antibodies exist. Decision is specialist-only due to thrombosis risk. haematologica.org

(Items intentionally omitted: there simply aren’t 20 distinct, evidence-supported drug classes specifically useful in BSS. The list above focuses on the core, guideline/label-anchored options clinicians actually use.)

---

Dietary molecular supplements

1) Iron.
If you develop iron-deficiency from recurrent bleeding, iron repletion (dietary iron + oral/IV supplements as directed) restores hemoglobin and improves energy. Excess iron can be harmful—dose only under clinical guidance. U.S. Food and Drug Administration

2) Folate (vitamin B9).
Supports red blood cell production; deficiency worsens anemia. Most people can meet needs through diet/standard supplements; high-dose folate should be clinician-directed. U.S. Food and Drug Administration

3) Vitamin B12.
Essential for normal red blood cell formation; deficiency causes anemia and fatigue. Treat true deficiency after testing; routine megadoses aren’t needed otherwise. U.S. Food and Drug Administration

4) Vitamin C.
Improves non-heme iron absorption and supports connective-tissue health; sensible doses with iron-rich meals are reasonable. Very high doses can cause GI upset. U.S. Food and Drug Administration

5) Copper.
Severe deficiency is uncommon but can cause anemia/neutropenia; avoid unnecessary high-dose use—supplement only if deficient. nctr-crs.fda.gov

6) Vitamin D.
General bone/immune support; not a hemostatic agent. Supplement per routine guidelines if you’re deficient. U.S. Food and Drug Administration

7) Protein-adequate diet.
Adequate protein supports wound healing; aim for balanced intake from food first; supplements only if dietary intake is low. WFH

8) Avoid high-dose omega-3s (fish oil) near procedures.
Some evidence and expert guidance caution about bleeding with high-dose omega-3, especially around surgery—coordinate with your clinician. FDA Access Data

9) Avoid high-dose garlic supplements.
Garlic products can have antiplatelet effects; stop before procedures unless your clinician says otherwise. FDA Access Data

10) Avoid ginkgo biloba.
Linked to bleeding events and drug interactions; generally avoid with platelet disorders unless your clinician approves. FDA Access Data

---

Immunity booster / regenerative / stem-cell” therapies

1) Allogeneic hematopoietic stem-cell transplantation (HSCT).
HSCT replaces the blood-forming system with donor cells and is potentially curative for severe, refractory BSS but used rarely due to risks (graft-versus-host disease, infection). Reported successful cases exist when bleeding was life-threatening and transfusion-refractory. haematologica.org

2) Gene therapy (investigational).
Future strategies may correct GP1BA/GP1BB/GP9 defects in a patient’s own stem cells, but no approved gene therapy for BSS exists yet. PMC

3) Romiplostim (Nplate®; TPO receptor agonist).
Off-label in inherited thrombocytopenias to raise platelet counts in selected situations (e.g., preparing for procedures); not BSS-specific and carries thrombosis risks—specialist-only. Label: Nplate®. FDA Access Data+1

4) Eltrombopag (Promacta®).
Off-label consideration similar to romiplostim; approved for ITP/aplastic anemia, not BSS. Liver toxicity and drug interactions require monitoring. Label: Promacta®. FDA Access Data

5) Avatrombopag (Doptelet®).
Approved for thrombocytopenia in chronic liver disease/procedural settings and ITP—not for BSS; off-label consultation only. Label: Doptelet®. FDA Access Data

6) Lusutrombopag (Mulpleta®).
Approved for periprocedural thrombocytopenia in chronic liver disease; not BSS-specific (off-label discussion only). FDA communication/label dossier: Mulpleta®. U.S. Food and Drug Administration+1

---

Surgical/procedural options

1) HSCT (bone-marrow/cord-blood transplant).
Considered only for severe, life-threatening, transfusion-refractory BSS; aims to cure by replacing the defective platelet lineage. Requires HLA matching and transplant expertise due to significant risks. haematologica.org

2) Nasal cauterization or arterial ligation (for recurrent epistaxis).
If nosebleeds recur from a visible anterior site, ENT may perform chemical/electrocautery; if bleeding is severe/recurrent from deeper sources, endoscopic arterial procedures can be used. PubMed

3) Endometrial ablation (or, rarely, hysterectomy) for refractory HMB.
For people finished with childbearing whose heavy periods persist despite medical therapy, gynecologic surgery can reduce bleeding burden and transfusion needs. ACOG

4) Dental/periodontal surgery with enhanced local hemostasis.
Extractions and deep cleanings are done safely when planned with hematology, using sutures, local hemostats, and antifibrinolytic mouthwash. WFH+1

5) (Rare) Splenectomy (case-by-case).
Not routine for BSS; occasionally considered for overlapping conditions. If pursued, vaccination and infection-prevention are essential. Medscape

---

Practical prevention tips

1. Avoid aspirin/NSAIDs unless your hematologist approves. haematologica.org

2. Tell every clinician/dentist you have BSS before any procedure. haematologica.org

3. Plan surgeries/dental work with hematology; have antifibrinolytics on hand. WFH

4. Protect your nose and gums (saline gel, soft toothbrush). AAO-HNS

5. Maintain dental hygiene to avoid invasive work. WFH

6. Use protective gear and choose low-impact activities. haematologica.org

7. Track periods; seek treatment for heavy bleeding early. contemporaryobgyn.net

8. Keep a first-aid kit with gauze and your care plan. haematologica.org

9. Be cautious with supplements that raise bleeding risk (ginkgo/garlic/high-dose omega-3). FDA Access Data+2FDA Access Data+2

10. Address anemia promptly (diet + iron as directed). U.S. Food and Drug Administration

---

When to see a doctor urgently

• Bleeding that won’t stop after 15–20 minutes of correct pressure (nose, wound). AAO-HNS

• Very heavy periods (soaking through a pad/tampon every 1–2 hours), passing large clots, or symptoms of anemia (fatigue, dizziness). contemporaryobgyn.net

• Bleeding after dental/surgical procedures, or blood in stool/urine. WFH

• Head injury or bleeding with weakness, fainting, or shortness of breath. haematologica.org

• Before any planned procedure (dental, surgery, childbirth). haematologica.org

---

Foods to favor and to avoid

Eat more of:

1. Iron-rich foods (lean red meat, poultry, fish, beans, lentils). Supports hemoglobin when bleeding is chronic. U.S. Food and Drug Administration

2. Vitamin-C-rich produce (citrus, berries, peppers) with plant iron meals to boost absorption. U.S. Food and Drug Administration

3. Leafy greens/folate sources (spinach, legumes). Support RBC production. U.S. Food and Drug Administration

4. B12 sources (eggs, dairy, fish; fortified foods if vegetarian/vegan). U.S. Food and Drug Administration

5. Adequate protein (eggs, dairy, tofu) for tissue repair. WFH

Limit/avoid:

1. High-dose omega-3 (fish oil) supplements around procedures due to bleeding concerns (food-level fish intake is usually fine). FDA Access Data
2. Ginkgo biloba supplements. Bleeding risk. FDA Access Data
3. High-dose garlic supplements. Antiplatelet effects. FDA Access Data
4. Excess alcohol, which can impair platelets and liver-based clotting factor synthesis. haematologica.org
5. Crash diets/iron blockers (e.g., tea with iron tablets)—separate tea/coffee from iron dosing to improve absorption. U.S. Food and Drug Administration

---

FAQs

1) Is BSS the same as ITP?
No. BSS is inherited with defective platelet adhesion; ITP is an immune condition destroying platelets. Misdiagnosis happens without specialized testing. haematologica.org

2) Which genes are involved?
Most often GP1BA, GP1BB, GP9, which encode the GPIb-IX-V complex on platelets. PMC

3) Why are my platelets “giant”?
They form abnormally in the marrow; the size doesn’t mean they work better—adhesion is still impaired. NCBI

4) Are antifibrinolytics (tranexamic/EACA) safe?
They’re widely used for mucosal bleeds; avoid in active intravascular clotting and use caution with hematuria. Follow your clinician’s dosing. PubMed+1

5) Do I need platelet transfusions often?
Usually only for major bleeds or procedures. Leukoreduced/ABO-identical units are standard; HLA matching/crossmatch is considered if antibodies develop. haematologica.org

6) What if I become “refractory” to platelets?
If anti-GPIb/IX or anti-HLA antibodies make transfusions fail, options include crossmatch/HLA-matched units and (in selected cases) rFVIIa. haematologica.org

7) Can DDAVP help?
Sometimes for mucosal bleeding, but benefit in BSS is inconsistent; it’s not a cure. AAO-HNS Bulletin

8) What about rFVIIa?
Used off-label, mainly when platelet transfusion isn’t possible or effective; thrombosis is a risk—specialist decision only. ResearchGate

9) Are there curative options?
HSCT can be curative in severe, refractory cases; it’s rare due to risks. Gene therapy is investigational. haematologica.org

10) How are nosebleeds handled at home?
Lean forward, pinch the soft nose, consider oxymetazoline/phenylephrine spray; seek care if not stopping. AAO-HNS+1

11) What should I tell my dentist?
“I have Bernard–Soulier syndrome”; request hemostatic planning (local agents + antifibrinolytic mouthwash) and coordinate with hematology. WFH

12) Heavy periods—what are my choices?
Tranexamic acid, hormonal contraception (including LNG-IUS), and, rarely, surgery—decided with gynecology and hematology. PubMed+1

13) Are there foods that “thin” blood?
High-dose ginkgo, garlic, omega-3 supplements can increase bleeding; food-level amounts are usually fine—ask your clinician. FDA Access Data+2FDA Access Data+2

14) Can I get pregnant?
Yes. Plan with obstetrics/hematology; delivery bleeding risk is higher, so a plan improves safety. haematologica.org

15) Who should coordinate my care?
A hematologist experienced in inherited platelet disorders, with ENT, dentistry, and gynecology as needed. haematologica.org

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 22, 2025.